FDA
-
-
-
-
-
-
-
Wall Street is Watching These Biotechs
-
-
-
-
-
-
-
Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers
-
-
-
-
-
-
-
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
-
-
-
-
-
-
-
NeOnc Technologies sets phase 2 dose for brain cancer drug NEO212
-
-
-
-
-
-
-
NeOnc Technologies Reports Updated Clinical Results
-
-
-
-
-
-
-
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
-
-
-
-
-
-
-
NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
-
327,820 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

